First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Clinical trial NCT07332455 · RECRUITING

Trial details

NCT number: NCT07332455
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms, Prostate

Start date: 2026-02-10
Primary completion: 2028-03-24
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.